SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Jul 28
 +7.16 / +2.84%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Biotech ETF.


1 month+0.73% 3 years+39.95%
3 months+14.02% 5 years+35.58%
1 year+73.35% Since inception+19.13%
Data through 07/28/2015

Quote Details

Previous close$251.78
Open day’s range249.99 – 259.74
Net asset value (NAV)251.67 (07/27/2015)
Daily volume1,184,950
Average volume (3 months)1,192,198
Data as of 3:59pm ET, 07/28/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+35.58%+26.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.421.74
Net assets$2.7B$2.0B
Average market cap$2.2B$37.5B
Average P/E--25.5
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RDUS Radius Health Inc1.32%
KYTH KYTHERA Biopharmaceuticals Inc1.28%
ZIOP ZIOPHARM Oncology Inc1.19%
NVAX Novavax Inc1.16%
EPZM Epizyme Inc1.15%
BCRX BioCryst Pharmaceuticals Inc1.10%
PRTA Prothena Corporation PLC1.09%
RARE Ultragenyx Pharmaceutical Inc1.08%
CMRX Chimerix Inc1.06%
MDXG MiMedx Group Inc1.06%

To view my watchlist

Not a member yet?

Sign up now for a free account